Fukuoka, Japan

Takenori Kenjo

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takenori Kenjo. Retrieved from https://idiyas.com/inventor/takenori-kenjo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takenori Kenjo

Introduction

Takenori Kenjo is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of psychotropic compositions. His work has led to the development of innovative compounds that exhibit potent effects.

Latest Patents

Kenjo holds a patent for "4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof." This patent includes 4,4-Diphenylcyclohexylpiperidine compounds and their analogs, which are designed to provide long-lasting psychotropic effects. The compounds are characterized by specific structural formulas that allow for various substitutions, enhancing their therapeutic potential.

Career Highlights

Kenjo is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative approach has contributed to the development of new psychotropic medications that aim to improve patient outcomes.

Collaborations

Kenjo has collaborated with esteemed colleagues such as Yoshinao Tsuda and Masafumi Arita. Their combined expertise has fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Takenori Kenjo's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions continue to influence the development of effective psychotropic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…